Drawing for KASERTA

USPTO serial 50083708

KASERTA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with KASERTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Devon E. White

Devon E. White Wyrick Robbins Yates & Ponton LLP4101 Lake Boone Trail, Suite 300Raleigh, NC 27607United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of infectious diseases; Therapeutic preparations, namely, antimicrobial and bacteriophage-based therapies for the treatment of infectious diseases; Pharmaceutical preparations comprised of bacteriophages for the treatment of bacterial infections, antimicrobial-resistant bacterial infections, diabetic foot infections, wound infections, and skin and soft tissue infections; Topical antimicrobial pharmaceutical preparations comprised of bacteriophages; Medicated topical preparations for the treatment of infected wounds; Medicated foot creamsACTIVE—
042Providing scientific data analysis and research services using pathogen surveillance, antimicrobial resistance, genomic, phenotypic, and epidemiological data to support pharmaceutical development, clinical trial planning, commercialization, and deployment of antimicrobial and bacteriophage-based therapies; Providing temporary use of non-downloadable software for collecting, analyzing, and providing pathogen surveillance data and antimicrobial resistance information; Software as a service (SaaS) featuring software for clinical decision support in the selection and optimization of antimicrobial and bacteriophage-based treatments; Platform as a service (PaaS) featuring software platforms for integrating infectious disease surveillance, therapeutic design, and treatment outcome tracking; Providing medical and scientific research information in the field of infectious diseases and antimicrobial resistance; Scientific data analysis and research services; Bioinformatics servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 1, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 1, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance